TACSTD2 and Parkinson disease: The GSEA results suggest that ENTPD1, SERPINA1, and TACSTD2 may be involved in the occurrence and development of PTC by jointly regulating the spliceosome, Parkinson’s disease, and cytokine–cytokine receptor interaction pathways.